Investigación
Educación
Soluciones
Iniciar sesión
ES
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Türkçe
JA - 日本語
PL - Polski
RU - Русский
HE - עִברִית
Department of Surgery,
Ellis Fischel Cancer Center,
Molecular Microbiology and Immunology
Xiaoqiang Qi has not added Biography.
If you are Xiaoqiang Qi and would like to personalize this page please email our Author Liaison for assistance.
Successful chemoimmunotherapy against hepatocellular cancer in a novel murine model.
Journal of hepatology Jan, 2017 | Pubmed ID: 27520877
Nanoliposome C6-Ceramide Increases the Anti-tumor Immune Response and Slows Growth of Liver Tumors in Mice.
Gastroenterology 03, 2018 | Pubmed ID: 29408569
Sunitinib and Sorafenib Modulating Antitumor Immunity in Hepatocellular Cancer.
Journal of immunology research and therapy , 2018 | Pubmed ID: 30123861
Disruption of oncogenic liver-intestine cadherin (CDH17) drives apoptotic pancreatic cancer death.
Cancer letters Jul, 2019 | Pubmed ID: 31004701
University of Missouri-Columbia
Xiaoqiang Qi*,1,2,3,
Emily Schepers*,1,2,
Diego Avella1,2,
Eric T. Kimchi1,2,
Jussuf T. Kaifi1,2,
Kevin F. Staveley-O'Carroll1,2,
Guangfu Li1,2,3
1Department of Surgery, University of Missouri-Columbia,
2Ellis Fischel Cancer Center, University of Missouri-Columbia,
3Molecular Microbiology and Immunology, University of Missouri-Columbia
Privacidad
Condiciones de uso
Políticas
Contáctenos
RECOMIENDE A LA BIBLIOTECA
BOLETINES de JoVE
JoVE Journal
Colecciones de métodos
JoVE Encyclopedia of Experiments
Archivo
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Centro de recursos académicos
Autores
Bibliotecarios
Acceso
ACERCA DE JoVE
Copyright © 2025 MyJoVE Corporation. Todos los derechos reservados